Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility

ISARIC4C Investigators, Carolina Rosadas, Maryam Khan, Eleanor Parker, Federica Marchesin, Ksenia Katsanovskaja, Macià Sureda-Vives, Natalia Fernandez, Paul Randell, Ruth Harvey, Alice Lilley, Benjamin H.L. Harris, Mohamed Zuhair, Michael Fertleman, Samreen Ijaz, Steve Dicks, Charlotte-Eve Short, Rachael Quinlan, Graham P. Taylor, Kai HuPaul Mckay, Annachiara Rosa, Chloe Roustan, Mark Zuckerman, Kate El Bouzidi, Graham Cooke, Barnaby Flower, Maya Moshe, Paul Elliott, Alexandra J. Spencer, Teresa Lambe, Sarah C. Gilbert, Hugh Kingston, J Kenneth Baillie, Peter J.M. Openshaw, Malcolm G. Semple, Peter Cherepanov, Myra O. Mcclure, Richard S. Tedder*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

16 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility'. Together they form a unique fingerprint.

Medicine & Life Sciences